News
-
-
COMMUNIQUÉ DE PRESSE
Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Redwood AI Corp. partners with Brent Page Lab at UBC for research on Alzheimer's disease drugs using AI-driven computational platform and medicinal chemistry expertise -
-
-
COMMUNIQUÉ DE PRESSE
Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Redwood AI Corp. selected to present at BIO-Europe Spring 2026, showcasing AI-driven chemical synthesis platform, Reactosphere, for safer and efficient decision-making in chemistry. CEO Louis Dron to present on March 25, 2026, in Lisbon, Portugal -
-
-
COMMUNIQUÉ DE PRESSE
Redwood AI CEO Louis Dron Featured on Conversations That Matter to Discuss AI Chemistry Platform and Broader Applications
Redwood AI Corp. CEO, Louis Dron, featured in an exclusive interview on Conversations That Matter, discussing the company's AI platform for pharmaceutical industry and broader chemistry-driven applications -
-
